31 results on '"Graham, Mindy K."'
Search Results
2. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
Catalog
Books, media, physical & digital resources
3. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer
4. Supplementary Tables 1-4 from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
5. Data from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
6. Supplementary Figures 1-6 from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
7. Supplementary Materials and Methods from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
8. Supplementary Figures 1-6 from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
9. Supplementary Materials and Methods from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
10. Supplementary Tables 1-4 from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
11. Data from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
12. Cover Image: Volume 83 Issue 3
13. Single‐cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate
14. Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate
15. Abstract 157: Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
16. Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate
17. Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
18. Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
19. Telomere alterations in neurofibromatosis type 1-associated solid tumors
20. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
21. Abstract B14: Establishment and characterization of in vitro models of alternative lengthening of telomeres (ALT) in pediatric high-grade glioma
22. Genetic alterations associated with ALTered telomeres
23. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
24. MYC drives overexpression of telomerase RNA ( hTR / TERC ) in prostate cancer
25. Abstract 3412: Functional knockout ofATRXorDAXXpermits the alternative lengthening of telomeres (ALT) mechanism in prostate cancer cells
26. Abstract 3464: CRISPR-mediated inactivation of ATRX and DAXX in pancreatic neuroendocrine tumor cell lines
27. Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
28. Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
29. Abstract 4767: Generating and characterizing novel prostate cancer cell lines that employ the alternative lengthening of telomeres (ALT) telomere maintenance mechanism
30. Targeting the Human Androgen Receptor Gene with Platinated Triplex-Forming Oligonucleotides
31. Inhibition of transcription by platinated triplex-forming oligonucleotides
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.